Diabetes Clinical Trials in Massachusetts

Showing 501-520 of 534 trials

Third Optimizing Anti-Platelet Therapy in Diabetes MellitUS (OPTIMUS-3)

NCT00642174

This trial is designed as a phase 2 randomized, double-blind double dummy, active comparator controlled, two-period two-arm crossover study to enroll 40 patients across multiple centers. The study will compare platelet function following a prasugrel loading dose and 1 week of prasugrel maintenance therapy with high-dose clopidogrel loading dose and 1 week of high-dose clopidogrel maintenance therapy in patients with drug treated type 2 diabetes mellitus who have coronary artery disease. Various assays of platelet function will be used in this study. Platelet function will be studied using the following assays: Accumetrics VerifyNowTM P2Y12, Light Transmittance Aggregometry (LTA), Vasodilator-associated stimulated phosphoprotein (VASP), and Thromboelastography (TEG)-platelet mapping.

Diabetes MellitusCoronary Artery Disease

Eli Lilly and Company35 participantsStarted Apr 2008

Jacksonville, Florida, United States • Worcester, Massachusetts, United States • New York, New York, United States +1 more locations

TERMINATEDPhase 318 miles

A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With COPD

NCT00138671

A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics with Chronic Obstructive Pulmonary Disease.

Diabetes MellitusChronic Obstructive Pulmonary Disease

Pfizer105 participantsStarted Jan 2003

Glendale, Arizona, United States • Peoria, Arizona, United States • Phoenix, Arizona, United States +85 more locations

Third Optimizing Anti-Platelet Therapy in Diabetes MellitUS (OPTIMUS-3)

A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With COPD

Diabetes Trials in Other Cities

The LANCET Trial: A Trial of Long-acting Insulin Injection to Reduce C-reactive Protein in Patients With Type 2 Diabetes

Diabetes Control and Complications Trial (DCCT)

Exubera Large Simple Trial To Evaluate Long-Term Pulmonary And Cardiovascular Safety

Effect of Immediate Hemoglobin A1c on Glycemic Control in Children With Type I Diabetes Mellitus

Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone

Obese Patients With Type 2 Diabetes

GALLEX 6: Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes Mellitus

GALLEX 9: Safety and Tolerability of Oral Tesaglitazar When Added to Insulin Therapy in Patients With Type 2 Diabetes

Mitiglinide in Combination With Metformin vs. Metformin Alone in Patients With Type 2 Diabetes Mellitus

Study Evaluating Rimonabant Efficacy in Insulin-Treated Diabetic Patients(ARPEGGIO)

A Study for Type 2 Diabetic Patients

GALLANT 14 Tesaglitazar vs. Metformin and Fenofibrate

Comparison of Two Basal Insulins for Patients With Type 2 Diabetes (IOOY)

GALLANT 6 Tesaglitazar vs. Pioglitazone

Effects of Metformin Hydrochloride (HCl) in Combination With Colesevelam HCl, Compared to Metformin HCl Alone, in Patients With Type 2 Diabetes Mellitus and the Effects of Colesevelam HCl on Lipids and Glucose on Pre-diabetic Patients.

Comparison of Two Basal Insulin Therapies for Patients With Type 1 Diabetes

Pancreas Allotransplantation for Diabetic Nephropathy and Mild Chronic REnal fAilure Stage Study

Mechanism of Action and Efficacy of Muraglitazar in Type 2 Diabetes

Other Conditions in Massachusetts